我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
2
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2009
招募中
100.0%
暂无批准数据
- Union Minister Dr. Jitendra Singh has called for a nationwide mission-mode response to the interconnected rise of liver disease, Type-2 diabetes, and metabolic disorders now affecting younger adults and adolescents in India. - Speaking at the third anniversary of the InFLiMeN network, the Minister emphasized that fatty liver, hypertension, dyslipidaemia, and insulin resistance are closely linked and predispose one another. - India's unique metabolic profile—including genetic predisposition, central obesity, and the "Indian phenotype"—demands locally generated research data rather than reliance on international evidence alone. - The Minister highlighted the role of the National Liver Biobank, genomics, AI, and precision medicine in enabling early diagnosis and tailored treatments, while stressing that public awareness and behavioral change are equally critical.